Targeted Nanoparticles Boost Arsenic's Anticancer Punch

Links shared publicly online about this topic.

1,879
total visits

Targeted Nanoparticles Boost Arsenic's Anticancer Punch

Arsenic trioxide has a long history as a potent human poison, but it also has proven valuable as one of the primary treatment options for acute promyelocytic leukemia. Efforts to use arsenic trioxide to treat other types of cancer are under way, but clinical trials are revealing that the extreme toxicity ...

View full resource at physorg.com

Tags: Emergency, Poison, Cancer, Leukemia, Clinical Trial

Most Recently Shared on July 22, 2009 at 5:47 pm By:

FightCancer

Targeted Nanoparticles Boost Arsenic`s Anticancer Punch http://bit.ly/fyaRx

3 years ago...

Retweet

Favorite

Targeted nanoparticles boost arsenic's anticancer punch

news-medical.net — “Arsenic trioxide has a long history as a potent human poison, but it also has proven valuable as one of the primary treatment options for acute promyelocytic leukemia. Efforts to use arsenic trioxide to treat other types of cancer are under way, but clinical trials are revealing that the extreme toxicity of this material is likely to limit its utility as a broad-spectrum anticancer agent.” View full resource at news-medical.net